We found a significant increase of CD45+ cells, CD8+ T cells, and CD8/Treg ratio in the tumor tissues with either β-lap or anti-PD-L1 monotherapy, and these effects were dramatically magnified in the combination group (Fig. 6g). This evidence concerns the gene CD8A and neoplasm.